The Claim
In adults with Alzheimer's disease, 8 weeks of daily creatine monohydrate supplementation at 20 grams per day is associated with increased lymphocyte ATP and ADP levels in both sexes and increased mitochondrial respiration in females only.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In adults with Alzheimer's disease, taking 20 grams of creatine monohydrate daily for 8 weeks is linked to higher levels of ATP and ADP in immune cells in both men and women, and higher mitochondrial respiration in women only.
See the scientific wording
In adults with Alzheimer's disease, 8 weeks of daily creatine monohydrate supplementation at 20 grams per day is associated with increased lymphocyte ATP and ADP in both sexes and increased mitochondrial respiration in females only, suggesting sex-specific bioenergetic responses may exist but require confirmation in controlled trials.
When creatine is taken daily, it enters blood cells and gets converted into a high-energy storage molecule that quickly replenishes ATP when energy is needed. This keeps ATP and ADP levels high in the cells. In women, this process also makes the energy-producing parts of the cells work harder, increasing their oxygen use, but this stronger effect does not happen in men.
What the research says
1 studyStudy: Bioenergetic data from a creatine monohydrate pilot trial in Alzheimer's disease
In people with Alzheimer’s, taking 20g of creatine daily for 8 weeks boosted energy molecules in blood cells for both men and women, but only improved energy production in the mitochondria of women. The study found exactly what the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.